Straumann Holding AG · SIX:STMN
Straumann — Deutsche Bank Swiss Equities Conference 2011
16 slides from Straumann's conference presentation, May 17, 2011
Slide 1: To be the partner of choice
To be the partner of choice Franz Maier EVP Head of Sales at the Deutsche Bank Swiss Equities conference 17 May 2011 Disclaimer This presentation contains certain “forward-looking statements”, which can be identified by the use of terminology such as “will”, “guidance”, “would”, “prevailing”, “still
Slide 2: Agenda / Highlights in 2011
Agenda Highlights in 2011 Business performance Eventful first-quarter Outlook Questions & answers STRAUMANN May 2011 © by Straumann. All rights reserved. 3 Highlights in 2011 2
Slide 3: Straumann achieves growth in all regions
Straumann achieves growth in all regions Net revenue up 4.3% (l.c.) driven by implant volumes (Bone Level, Roxolid®) and lifted by new products (scanners and regeneratives) APAC slightly impacted by disaster in Japan; future negative effects anticipated Strong currency headwind, cutting CHF 19 milli
Slide 4: Business performance
Business performance Stable growth in l.c. for five consecutive quarters Group organic growth1 by quarter (l.c.) Growth by region 7% 17% 5% 15% 4% 3% 2% 3% 8% 4% 2% 2% -1% -1% 0% Q1 Q2 Q3 Q4 Q1 Q2 Q3 Q4 Q1 -4% -5% -9% -8% Europe North Asia/Pacific ROW Group America 2009 2010 2011 l.c. CHF 1 ’Organic
Slide 5: Unprecedented currency headwind in Q1; Europe edges forward
Unprecedented currency headwind in Q1 USDCHF 1.2 Ø exchange rates (rounded numbers) FY 2009 FY 2010 Spot 1.1 EURCHF 1.51 1.38 1.26 1 USDCHF 1.08 1.04 0.89 JPYCHF 1.16 1.19 1.10 0.9 0.8 Jan Feb Mrz Apr Mai Jun Jul Sep Okt Nov Dez EURCHF 1.5 1.4 1.3 1.2 2010 1.1 2011 Jan Feb Mrz Apr Mai Jun Jul Sep Ok
Slide 6: Momentum continues in North America; Asia mixed
Momentum continues in North America Record quarter in the US, but weak USD squeezes revenue growth in Swiss francs Growth in l.c. driven by implant volumes Additional lift from Straumann® Allograft Consumers still cautious about spending (in CHF million) Q1 10 Q1 11 ∆ % in CHF Net revenue 41.6 40.1
Slide 7: Eventful first quarter
Too early to quantify tsunami impact in Japan Significant impact not evident in Q1 figures as disaster struck towards end of quarter Straumann staff and facilities not directly affected Dental practices affected by power outages Bone Level implant launched in March and well received Japan contribute
Slide 8: Collaboration to create the leading standard
Collaboration to create the leading standard Present dilemma: too many incompatible systems; confusion; limited growth opportunities Straumann and 3M ESPE adopt DWOS and join forces with Dental Wings to establish a leading software standard in digital dentistry Straumann announces intention to acqui
Slide 9: Substitution of an unpleasant treatment step
Substitution of an unpleasant treatment step Analogue impression-taking (Digital) intra-oral scanning with in the dental practice the iTero handheld scanner STRAUMANN May 2011 © by Straumann. All rights reserved. 17 Seamless connectivity with Straumann® CARES® Dentist Dental technician Straumann CAD
Slide 10: Leading material offering and application range
Leading material offering and application range Ceramics1 Metals1 Polymers1 Zirconium IPS Empress® CAD2 Titanium abutment Polyamide dioxide abutment zerion™ VITA TriLuxe3 coron® polycon® ae IPS e.max® CAD2 VITA Mark II2 ticon® polycon® cast 1 Products may require regulatory approvals and may not be
Slide 11: 'Peace of mind' for clinicians and patients
‘Peace of mind’ for clinicians and patients Straumann® warranty extended Clear warranty conditions for Straumann Dental Implant System and CARES® elements Life-time warranty for implants and abutments in certain countries Straumann® All-in-one Sets1 Kit contains all components for complete restorati
Slide 12: Outlook 2011 (barring unforeseen circumstances)
Outlook 2011 (barring unforeseen circumstances) Straumann assumes mid-single-digit market growth (in l.c.) for 2011 The Group is convinced it can again deliver above-market performance Currency headwind has to be expected for some time in 2011 It is difficult to predict the impact of recent events i
Slide 13: Question & answer session
Excellent value and reliability Time-tested SLA surface enables Straumann to compete effectively in the value segment One-stage surgical procedure saves time, costs and discomfort for patients 10-year Proven long-term reliability; 10-year results data from randomized controlled clinical trial1 STRAU
Slide 14: Calendar of upcoming events; A leader in markets worth >CHF 5bn
Calendar of upcoming events 27 May Helvea Healthcare Trip Basel 29 June Investor roadshow London 30 June Nomura Healthcare conference London 16 August Half-Year results 2011 Basel Detailed calendar on www.straumann.com STRAUMANN May 2011 © by Straumann. All rights reserved. 27 A leader in markets wo
Slide 15: Net revenue growth by quarter
Net revenue growth by quarter CHF million Q1 2010 Q2 2010 Q3 2010 Q4 2010 Q1 2011 Europe 125.0 116.6 92.4 110.9 113.9 growth in % CHF (0.2) (2.0) (9.0) (4.9) (8.8) growth in % l.c. 1.4 3.9 1.2 6.4 2.2 North America 41.7 43.6 38.2 41.3 40.1 growth in % CHF 3.6 8.9 3.6 8.1 (3.7) growth in % l.c. 8.4 7
Slide 16: Your investor relations contacts
Your investor relations contacts Fabian Hildbrand Corporate Investor Relations Phone +41 (0)61 965 13 27 Mobile +41 (0)79 392 80 32 Email fabian.hildbrand@straumann.com Deborah Capobianco Investor Relations Coordination Phone +41 (0)61 965 12 66 Email deborah.capobianco@straumann.com STRAUMANN May 2
Straumann Holding — Deutsche Bank Swiss Equities Conference 2011 on 6ix